Printer Friendly Tell a Friend

Navy condemns FDA for obstructing vital medical research

The U.S. Food and Drug Administration has many critics, but none are more angry than those who have lost loved ones — or who are about to lose their own lives — because the FDA has blocked their access to life-saving treatments. Now these critics have a new and unexpected ally: the United States Navy.1

For the past four years the U.S. Navy has been trying to gain FDA approval for a clinical trial of a blood substitute being developed by Biopure Corporation. The blood substitute, “Hemopure”, is a fluid containing cell-free hemoglobin extracted from bovine red blood cells, and salts like those found in blood.7

The FDA has refused to allow these clinical trials, citing safety concerns. Meanwhile, for lack of useable blood or blood substitute, countless people have died before reaching hospitals.2

The situation is similar to that faced by millions of people with terminal diseases who are unable to obtain potentially life-saving treatments because of FDA nit-picking over clinical data. This agency would prefer to have a hundred thousand people die from not having access to a new treatment than to risk having a hundred people die from potential side effects. Why? Because when a hundred people die from side effects, it makes the news and the FDA gets criticized. When a hundred thousand people die from drug unavailability, nobody pays any attention.

During the first decade or so of the AIDS epidemic, tens of thousands of AIDS patients died unnecessarily because of FDA foot-dragging and screwy priorities. The situation hasn’t really improved much since then, judging by this latest flap over blood substitutes.3,4

The situation for nutritional supplements is not quite as bad as it is for drugs and other medical treatments — thanks to the Dietary Supplement Health and Education Act of 1994, which has largely protected supplement users from the kind of totalitarian action which the FDA directs at the medical world.5 However, the FDA and its counterparts in other countries have had a basic antipathy toward vitamins and other dietary supplements, and we would all be better off if the next FDA commissioner is someone with a libertarian viewpoint rather than a totalitarian one.6


To get our newsletter please enter your email address in the box below and press 'Subscribe' button.